| Publication | Date of Publication | Type |
|---|
| Two-sample tests of area-under-the-curve in the presence of missing data | 2024-11-27 | Paper |
| Testing for associations with missing high-dimensional categorical covariates | 2024-11-27 | Paper |
| Targeted maximum likelihood estimation of effect modification parameters in survival analysis | 2024-11-27 | Paper |
| Resampling-based methods in single and multiple testing for equality of covariance/correlation matrices | 2024-11-27 | Paper |
| A general implementation of TMLE for longitudinal data applied to causal inference in survival analysis | 2024-11-27 | Paper |
| Predicting time to threshold for initiating antiretroviral treatment to evaluate cost of treatment as prevention of human immunodeficiency virus | 2024-11-14 | Paper |
| Locally efficient estimation of marginal treatment effects when outcomes are correlated: is the prize worth the chase? | 2024-11-05 | Paper |
| Estimating contact network properties by integrating multiple data sources associated with infectious diseases | 2024-10-29 | Paper |
| A flexible nonlinear mixed effects model for HIV viral load rebound after treatment interruption | 2024-10-29 | Paper |
| Novel methods for the analysis of stepped wedge cluster randomized trials | 2024-10-29 | Paper |
| Efficient estimation of human immunodeficiency virus incidence rate using a pooled cross-sectional cohort study design | 2024-10-29 | Paper |
| Discussion of article by Ellenberg and Morris | 2024-10-29 | Paper |
| Investigation of patient-sharing networks using a Bayesian network model selection approach for congruence class models | 2024-10-29 | Paper |
| Bayesian reconstruction of transmission trees from genetic sequences and uncertain infection times | 2021-05-07 | Paper |
| Estimation of the overall treatment effect in the presence of interference in cluster-randomized trials of infectious disease prevention | 2019-07-11 | Paper |
| Accounting for interactions and complex inter‐subject dependency in estimating treatment effect in cluster‐randomized trials with missing outcomes | 2017-09-07 | Paper |
| Sampling dynamic networks with application to investigation of HIV epidemic drivers | 2015-12-21 | Paper |
| Flexible covariate-adjusted exact tests of randomized treatment effects with application to a trial of HIV education | 2014-03-28 | Paper |
| Accommodating Uncertainty in a Tree Set for Function Estimation | 2013-12-05 | Paper |
| Impact of Time to Start Treatment Following Infection with Application to Initiating HAART in HIV‐Positive Patients | 2012-11-19 | Paper |
| Recursive partitioning of resistant mutations for longitudinal markers based on a U-type score | 2012-10-29 | Paper |
| Characterizing the Relationship Between HIV-1 Genotype and Phenotype: Prediction-Based Classification | 2011-03-01 | Paper |
| Efficient hybrid EM for linear and nonlinear mixed effects models with censored response | 2009-06-02 | Paper |
| Resampling-Based Multiple Testing Methods with Covariate Adjustment: Application to Investigation of Antiretroviral Drug Susceptibility | 2008-06-13 | Paper |
| A Resampling-Based Approach to Multiple Testing with Uncertainty in Phase | 2008-02-18 | Paper |
| Combining Cross‐Sectional and Prospective Data Methods to Improve Transition Parameter Estimation for Characterizing the Accumulation of HIV‐1 Drug Resistance Mutations | 2008-01-14 | Paper |
| Joint Modeling of Progression of HIV Resistance Mutations Measured with Uncertainty and Failure Time Data | 2007-11-20 | Paper |
| Nonparametric Tests for Two‐Group Comparisons of Dependent Observations Obtained at Varying Time Points | 2007-11-20 | Paper |
| Hidden Markov models for settings with interval-censored transition times and uncertain time origin: application to HIV genetic analyses | 2007-09-12 | Paper |
| Combining Genotype Groups and Recursive Partitioning: An Application to Human Immunodeficiency Virus Type 1 Genetics Data | 2007-05-07 | Paper |
| A Flexible B‐Spline Model for Multiple Longitudinal Biomarkers and Survival | 2006-01-03 | Paper |
| Validation and Discovery in Markov Models of Genetics Data | 2005-10-28 | Paper |
| A Nonparametric Test of Gene Region Heterogeneity Associated With Phenotype | 2004-06-10 | Paper |
| A Model for Markers and Latent Health Status | 2001-09-17 | Paper |
| Strategies for cohort sampling under the Cox proportional hazards model, application to an AIDS clinical trial | 2000-04-12 | Paper |
| A class of semiparametric transormation frailty models with application to estimating treatment effects and heterogenity in aids clinical traials | 2000-01-01 | Paper |
| Nonparametric Mixed-Effects Models for Repeated Binary Data Arising in Serial Dilution Assays: An Application to Estimating Viral Burden in AIDS | 1999-04-28 | Paper |
| Modelling Progression of CD4-Lymphocyte Count and Its Relationship to Survival Time | 1995-11-28 | Paper |
| Regression Analysis of Censored and Truncated Data: Estimating Reporting- Delay Distributions and AIDS Incidence from Surveillance Data | 1995-11-28 | Paper |
| Modeling the Relationship of Survival to Longitudinal Data Measured with Error. Applications to Survival and CD4 Counts in Patients with AIDS | 1995-08-21 | Paper |
| Analyzing Doubly Censored Data with Covariates, with Application to AIDS | 1993-08-30 | Paper |
| Analysis of Doubly-Censored Survival Data, with Application to AIDS | 1989-03-01 | Paper |
| Analysis of Doubly-Censored Survival Data, with Application to AIDS | 1989-01-01 | Paper |
| Nonparametric analysis of truncated survival data, with application to AIDS | 1988-01-01 | Paper |
| Influence Analysis of Generalized Least Squares Estimators | 1987-01-01 | Paper |
